| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6534069 | 3M | Stable hydroalcoholic compositions |
Jun, 2015
(8 years ago) | |
| US6090395 | 3M | Stable hydroalcoholic compositions |
Jun, 2015
(8 years ago) | |
| US7566460 | 3M | Stable hydroalcoholic compositions |
Jun, 2015
(8 years ago) | |
| US6623744 | 3M | Stable hydroalcoholic compositions |
Jun, 2015
(8 years ago) | |
| US5897031 | 3M | Dispenser for antimicrobial liquids |
Jun, 2016
(7 years ago) | |
| US7081246 | 3M | Stable hydroalcoholic compositions |
Aug, 2016
(7 years ago) | |
Avagard is owned by 3M.
Avagard contains Alcohol; Chlorhexidine Gluconate.
Avagard has a total of 6 drug patents out of which 6 drug patents have expired.
Expired drug patents of Avagard are:
- US6534069
- US6090395
- US7566460
- US6623744
- US5897031
- US7081246
Avagard was authorised for market use on 07 June, 2001.
Avagard is available in solution;topical dosage forms.
Avagard can be used as application of antiseptic with moisturizers for surgical and healthcare personnel skin disinfection.
The generics of Avagard are possible to be released after 03 August, 2016.
Drugs and Companies using ALCOHOL; CHLORHEXIDINE GLUCONATE ingredient
Market Authorisation Date: 07 June, 2001
Treatment: Application of antiseptic with moisturizers for surgical and healthcare personnel skin disinfection
Dosage: SOLUTION;TOPICAL
AVAGARD family patents
